{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:42:54Z","timestamp":1765485774873},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ijsu.2014.05.017","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T12:18:51Z","timestamp":1400847531000},"page":"S225-S231","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S1","title":["The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: Our experience: A case report"],"prefix":"10.1097","volume":"12","author":[{"given":"Andrea","family":"Cavallaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Zangh\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Lo Menzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Di Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Card\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Di Mattia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cappellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2014.05.017_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib3","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2014.05.017_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1572-0241.2003.04027.x","article-title":"A\u00a050-year analysis of 562 gastric carcinoids: small tumor or larger problem?","volume":"99","author":"Modlin","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijsu.2014.05.017_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1245\/s10434-008-0192-8","article-title":"A\u00a0proposed staging system for gastric carcinoid tumors based on an analysis of 1543 patients","volume":"16","author":"Landry","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib7","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1200\/JCO.2005.05.218","article-title":"Expression of neuroendocrine markers in undifferentiated carcinomas of the gastrointestinal tract","volume":"23","author":"Grabowski","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000098013","article-title":"Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic)","volume":"84","author":"Nilsson","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ijsu.2014.05.017_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijsu.2014.05.017_bib10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s00428-007-0461-0","article-title":"Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors","volume":"451","author":"Kl\u00f6ppel","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ijsu.2014.05.017_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000098007","article-title":"Well-differentiated NE gastric tumors\/carcinomas","volume":"84","author":"Ruszniewski","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ijsu.2014.05.017_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-59655-1","article-title":"Histological Typing of Endocrine Tumours","author":"Solcia","year":"2000"},{"key":"10.1016\/j.ijsu.2014.05.017_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/cncr.20939","article-title":"Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases","volume":"103","author":"Soga","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2014.05.017_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0016-5085(99)70174-5","article-title":"ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis","volume":"116","author":"Rindi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijsu.2014.05.017_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11938-007-0064-5","article-title":"Treatment of gastric carcinoids","volume":"10","author":"Hou","year":"2007","journal-title":"Curr. Treat. Opin. Gastroenterol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger\u2013Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Med. Baltim."},{"key":"10.1016\/j.ijsu.2014.05.017_bib17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.surg.2004.06.057","article-title":"Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger\u2013Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment","volume":"136","author":"Norton","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.ijsu.2014.05.017_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00795-005-0293-4","article-title":"Primary gastric small cell carcinoma: report of a case and review of the literature","volume":"38","author":"Namikawa","year":"2005","journal-title":"Med. Mol. Morphol."},{"issue":"4","key":"10.1016\/j.ijsu.2014.05.017_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/00365521.2013.878381","article-title":"Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge","volume":"49","author":"Lahner","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ijsu.2014.05.017_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3748\/wjg.v20.i1.118","article-title":"Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors","volume":"20","author":"Li","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijsu.2014.05.017_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-6147(00)88988-9","article-title":"Classification and nomenclature of somatostatin receptors","volume":"16","author":"Hoyer","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijsu.2014.05.017_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1\u2013SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ijsu.2014.05.017_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","article-title":"Evaluation of positron emission tomography imaging using 68Ga DOTA-Phe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors","volume":"51","author":"Kowalski","year":"2003","journal-title":"Mol. Imag. Biol."},{"issue":"12","key":"10.1016\/j.ijsu.2014.05.017_bib24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","article-title":"Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data","volume":"28","author":"Hofmann","year":"2001","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ijsu.2014.05.017_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ijsu.2014.05.017_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ijsu.2014.05.017_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-642-27994-2_18","article-title":"Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET\/CT of gastroenteropancreatic neuroendocrine tumors","volume":"194","author":"Poeppel","year":"2013","journal-title":"Rec. Result. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijsu.2014.05.017_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrendo.2013.246","article-title":"Neuroendocrine tumours: the role of imaging for diagnosis and therapy","volume":"10","author":"Van Essen","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.ijsu.2014.05.017_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bpg.2013.01.004","article-title":"Peptide receptor radionuclide therapy (PRRT) for GEP-NETs","volume":"26","author":"Bergsma","year":"2012","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ijsu.2014.05.017_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2967\/jnumed.113.125336","article-title":"Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-Octreotate","volume":"55","author":"Ezziddin","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ijsu.2014.05.017_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM200008243430805","article-title":"Treatment of type II gastric carcinoid tumors with somatostatin analogues","volume":"343","author":"Tomassetti","year":"2000","journal-title":"N\u00a0Engl. J. Med."},{"issue":"Suppl.\u00a07","key":"10.1016\/j.ijsu.2014.05.017_bib32","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2014.05.017_bib33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A\u00a0prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijsu.2014.05.017_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.gtc.2007.08.006","article-title":"Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors","volume":"36","author":"Rindi","year":"2007","journal-title":"Gastroenterol. Clin. N Am."},{"issue":"2","key":"10.1016\/j.ijsu.2014.05.017_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335595","article-title":"ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms","volume":"95","author":"Delle Fave","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ijsu.2014.05.017_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2741\/s73","article-title":"Clinical and biological markers in gastric cancer: update and perspectives","volume":"2","author":"Cappellani","year":"2010","journal-title":"Front. Biosci. Sch. Ed."},{"issue":"1","key":"10.1016\/j.ijsu.2014.05.017_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1477-7819-11-172","article-title":"Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management","volume":"11","author":"Cappellani","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ijsu.2014.05.017_bib38","first-page":"727","article-title":"The neo-adjuvant treatment in gastrointestinal stromal tumor","volume":"14","author":"Catania","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ijsu.2014.05.017_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.archger.2008.01.014","article-title":"Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer","volume":"48","author":"Malaguarnera","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"2","key":"10.1016\/j.ijsu.2014.05.017_bib40","first-page":"137","article-title":"Surgery on gastrountestinal stromal tumor CD117+ (G.I.S.T.): personal experience","volume":"77","author":"Cavallaro","year":"2006","journal-title":"Ann. Ital. Chir."},{"key":"10.1016\/j.ijsu.2014.05.017_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2741\/s87","article-title":"Molecular diagnosis of pancreatic cancer: where do we stand?","volume":"2","author":"Lo Menzo","year":"2010","journal-title":"Front. Biosci. (Schol. Ed.)"},{"issue":"4","key":"10.1016\/j.ijsu.2014.05.017_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.14310\/horm.2002.1439","article-title":"The validity of current guidelines regarding surgical management of patients with gastric neuroendocrineneoplasms type 1: a report of a series of seven patients","volume":"12","author":"Boutzios","year":"2013","journal-title":"Horm. (Athens)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919114001162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919114001162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:00:12Z","timestamp":1677063612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919114001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"alternative-id":["S1743919114001162"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.017","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: Our experience: A case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}